Cargando…
Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design
Asthma is a chronic inflammatory airway disease. Increase in airway inflammation is hypothesised to contribute to worsening of asthma symptoms and deterioration in lung function, resulting in the use of reliever medication. Short-acting β(2)-agonists only treat the symptoms, whereas an anti-inflamma...
Autores principales: | Harrison, Tim, Pavord, Ian D., Chalmers, James D., Whelan, Glenn, Fagerås, Malin, Rutgersson, Annika, Belton, Laura, Siddiqui, Shahid, Gustafson, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276524/ https://www.ncbi.nlm.nih.gov/pubmed/32550224 http://dx.doi.org/10.1183/23120541.00333-2019 |
Ejemplares similares
-
Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis
por: Beasley, Richard, et al.
Publicado: (2022) -
Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma
por: Beasley, Richard, et al.
Publicado: (2019) -
Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials
por: Hatter, Lee, et al.
Publicado: (2022) -
Can We Find Better Bronchodilators to Relieve Asthma Symptoms?
por: Townsend, Elizabeth A., et al.
Publicado: (2012) -
Effect of body position on relieve of foreign body from the airway
por: Luczak, Artur
Publicado: (2019)